Literature DB >> 29713904

Gene expression changes in the retina after systemic administration of aldosterone.

Aoi Ono1, Kazuyuki Hirooka2, Yuki Nakano2, Eri Nitta2, Akira Nishiyama3, Akitaka Tsujikawa2.   

Abstract

PURPOSE: Retinal ganglion cell (RGC) loss associated with thinning of the retinal nerve fiber layer without elevated intraocular pressure (IOP) occurs after the systemic administration of aldosterone. Since it is important to determine the mechanism of cell death independent of the IOP, we examined gene expression changes in the retina after the systemic administration of aldosterone.
METHODS: Following subcutaneous implantation of an osmotic minipump into the mid-scapular region of rats, we administered an 80 μg/kg/day dose of aldosterone. Differences in the gene expression in the retina between normal rats and aldosterone-treated rats were investigated using microarrays. Real-time PCR was used to confirm the differential expression.
RESULTS: Analysis of the microarray data sets revealed the upregulation of 24 genes and the downregulation of 24 genes of key apoptosis-specific genes. Real-time PCR revealed 4 genes (Cdkn1a, Tbox5, Pf4, Vdr) were upregulated while 12 genes (Acvr1c, Asns, Bard1, Card9, Crh, Fcgr1a, Inhba, Kcnh8, Lck, Phlda1, Ptprc, Sh3rf1) were downregulated.
CONCLUSIONS: Significant increases and decreases were noted in several genes after the systemic administration of aldosterone. Further studies will need to be undertaken in order to definitively clarify the role of these genes in the eyes of animals with normal-tension glaucoma.

Entities:  

Keywords:  Aldosterone; Glaucoma; Microarray; Retina; Retinal ganglion cell

Mesh:

Substances:

Year:  2018        PMID: 29713904     DOI: 10.1007/s10384-018-0595-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  40 in total

1.  Albuminuria in untreated patients with primary aldosteronism or essential hypertension.

Authors:  J M Halimi; A Mimran
Journal:  J Hypertens       Date:  1995-12       Impact factor: 4.844

Review 2.  p53 and mitochondrial function in neurons.

Authors:  David B Wang; Chizuru Kinoshita; Yoshito Kinoshita; Richard S Morrison
Journal:  Biochim Biophys Acta       Date:  2014-01-08

3.  Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases.

Authors:  Yimin Wang; Amani A Fawzi; Rohit Varma; Alfredo A Sadun; Xinbo Zhang; Ou Tan; Joseph A Izatt; David Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-11       Impact factor: 4.799

4.  Unequal intraocular pressure and its relation to asymmetric visual field defects in low-tension glaucoma.

Authors:  A Crichton; S M Drance; G R Douglas; M Schulzer
Journal:  Ophthalmology       Date:  1989-09       Impact factor: 12.079

Review 5.  Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP.

Authors:  R A Cohen; P M Vanhoutte
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

6.  The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Müller glial cells.

Authors:  Min Zhao; Fatemeh Valamanesh; Isabelle Celerier; Michèle Savoldelli; Laurent Jonet; Jean-Claude Jeanny; Frederic Jaisser; Nicolette Farman; Francine Behar-Cohen
Journal:  FASEB J       Date:  2010-05-13       Impact factor: 5.191

7.  Evidence that nitric oxide is involved in autoregulation in optic nerve head of rabbits.

Authors:  Takashi Okuno; Hidehiro Oku; Tetsuya Sugiyama; Ying Yang; Tsunehiko Ikeda
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

8.  Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.

Authors:  Kouki Fukuda; Kazuyuki Hirooka; Masanori Mizote; Takehiro Nakamura; Toshifumi Itano; Fumio Shiraga
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

9.  Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats.

Authors:  Kazim Husain; Leon Ferder; Masahide Mizobuchi; Jane Finch; Eduardo Slatopolsky
Journal:  Am J Nephrol       Date:  2008-11-26       Impact factor: 3.754

10.  Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.

Authors:  Jennifer L Wilkinson-Berka; Genevieve Tan; Kassie Jaworski; Jacqueline Harbig; Antonia G Miller
Journal:  Circ Res       Date:  2008-11-26       Impact factor: 17.367

View more
  3 in total

1.  The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma.

Authors:  Kazuyuki Hirooka; Yoshiaki Kiuchi
Journal:  Antioxidants (Basel)       Date:  2022-03-22

2.  c-Kit Induces Migration of Triple-Negative Breast Cancer Cells and Is a Promising Target for Tyrosine Kinase Inhibitor Treatment.

Authors:  José A López-Mejía; Luis F Tallabs-Utrilla; Pablo Salazar-Sojo; Jessica C Mantilla-Ollarves; Manuel A Sánchez-Carballido; Leticia Rocha-Zavaleta
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

3.  The association of primary aldosteronism with glaucoma-related fundus abnormalities.

Authors:  Yoshimi Ohshima; Tomomi Higashide; Kimikazu Sakaguchi; Makoto Sasaki; Sachiko Udagawa; Shinji Ohkubo; Takashi Yoneda; Kazuhisa Sugiyama
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.